Key facts
- It has raised $95.8M across 4 recorded rounds; the latest was Early Stage VC ($11.4M) in Sep 2024.
- Notable investors include JobsOhio Ventures, Rev1 Ventures, Stout Street Capital, Colorado Office of Economic Development & International Trade, University Hospitals Ventures — 13 tracked in total.
- STAQ Pharma has filed 9 Form Ds with the SEC since 2019, most recently Sep 2024 ($11.4M sold to 8 investors).
- Status: Privately Held (backing).
Investors
13+- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for STAQ Pharma
Funding rounds
4 roundsAbout STAQ Pharma
Operator of an FDA-registered outsourcing facility intended to provide safe, reliable, and high-quality compounded medications to healthcare providers. The company offers sterile, ready-to-use injectable drugs produced in CGMP-compliant facilities with rigorous quality controls, enabling hospitals and health systems to maintain consistent access to essential medications and ensure patient safety.
- Sector
- Healthcare
- HQ
- Denver, CO, United States
- Founded
- 2010
- Employees
- 93
- Website
- staqpharma.com/
- Ownership
- Privately Held (backing)
STAQ Pharma doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in STAQ Pharma shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on STAQ Pharma in its N-PORT filings yet. We sweep new filings monthly.